UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment

Journal of experimental & clinical cancer research, 2022-12, Vol.41 (1), p.344-9, Article 344

2022

Volltextzugriff (PDF)

Successful Consolidation/Maintenance Therapy with Single Agent Ibrutinib for Primary CNS Lymphoma after Initial Induction Therapy

Neurology international, 2022-06, Vol.14 (3), p.574-580

2022

Volltextzugriff (PDF)

Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4 + T-lymphocyte counts

CNS oncology, 2018-07, Vol.7 (3)

2018

Volltextzugriff (PDF)

A High-Grade Glioma, Not Elsewhere Classified in an Older Adult with Discordant Genetic and Epigenetic Analyses

Biomedicines, 2024-09, Vol.12 (9), p.2042

2024

Volltextzugriff (PDF)

Therapeutic Immunization against Glioblastoma

International journal of molecular sciences, 2018-08, Vol.19 (9), p.2540

2018

Volltextzugriff (PDF)

Intracranial meningioma with carcinoma tumor-to-tumor metastasis: two case reports

CNS oncology, 2018-04, Vol.7 (2), p.CNS09

2018

Volltextzugriff (PDF)

A Retrospective Interventional Cohort Study to Assess the Safety and Efficacy of Sandostatin LAR for Treatment of Recurrent and/or Refractory Meningiomas

Frontiers in neurology, 2020-05, Vol.11, p.373-373

2020

Volltextzugriff (PDF)

Cytarabine Induced Acute Cerebellar Syndrome during Hyper-CVAD Treatment for B-Cell Acute Lymphoblastic Leukemia

Case reports in neurology, 2017-05, Vol.9 (1), p.114-120

2017

Volltextzugriff (PDF)

A non-enhancing, T2 fluid-attenuated inversion recovery hyperintense, diffusion-restricting brainstem lesion in an EGFR tyrosine kinase inhibitor-treated non-small-cell lung cancer patient

Biomarkers in medicine, 2024, Vol.18 (9), p.431-441

2024

Volltextzugriff (PDF)

331 Tumor markers associated with increased survival in a phase II trial of dendritic cell/tumor-initiating-cell vaccine AV-GBM-1 in patients with newly diagnosed glioblastoma

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A357-A357

2021

Volltextzugriff (PDF)

333 Changes in proteomic markers after injections of personal AV-GBM-1 dendritic cell/tumor initiating cell vaccines in a phase II trial in patients with newly diagnosed glioblastoma

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A359-A359

2021

Volltextzugriff (PDF)

319 Phase II trial of immunotherapy in primary glioblastoma: antigens from self-renewing autologous tumor cells presented by autologous dendritic cell vaccine

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A345-A345

2020

Volltextzugriff (PDF)

Dabrafenib and steroids for the treatment of Erdheim-Chester disease with extensive CNS involvement: a case report

Personalized medicine, 2024, Vol.21 (2), p.71-78

2024

Volltextzugriff (PDF)

Big Potassium (BK) ion channels in biology, disease and possible targets for cancer immunotherapy

International immunopharmacology, 2014-10, Vol.22 (2), p.427-443

2014

Volltextzugriff (PDF)

Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment

International journal of radiation oncology, biology, physics, 2018-04, Vol.100 (5), p.1195-1203

2018

Volltextzugriff (PDF)

Successful desensitization protocol for delayed cutaneous eruption to temozolomide

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2014-09, Vol.2 (5), p.626-628

2014

Volltextzugriff (PDF)

p53 Mutants Have Selective Dominant-Negative Effects on Apoptosis but Not Growth Arrest in Human Cancer Cell Lines

Molecular and Cellular Biology, 2000-02, Vol.20 (3), p.770-778

2000

Volltextzugriff (PDF)

Mechanisms of Differential Activation of Target Gene Promoters by p53 Hinge Domain Mutants with Impaired Apoptotic Function

The Journal of biological chemistry, 2001-08, Vol.276 (35), p.32990-33000

2001

Volltextzugriff (PDF)

NIMG-78. THE ROLE OF FDG PET/CT IN MANAGING DIFFUSE MIDLINE GLIOMA WITH H3K27M MUTATION: A CASE STUDY AND PATHOLOGICAL CORRELATION

Neuro-oncology (Charlottesville, Va.), 2024-11, Vol.26 (Supplement_8), p.viii213-viii213

2024

Volltextzugriff (PDF)

NCOG-17. RETROSPECTIVE REVIEW OF THE TREATMENT OF VENOUS THROMBOEMBOLISM IN GLIOBLASTOMA PATIENTS RECEIVING BEVACIZUMAB

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v217-v217

2023

Volltextzugriff (PDF)

IMMU-54. PNEUMOCYSTIS JIROVECII PNEUMONIA INFECTION IN A PATIENT WITH ANAPLASTIC ASTROCYTOMA AND RADIATION NECROSIS IN THE SETTING OF CORTICOSTEROID AND PEMBROLIZUMAB USE

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v154-v155

2023

Volltextzugriff (PDF)

Rare Case of Primary Dural Based Marginal Zone B-Cell Lymphoma Camouflaging as Mild Focal Dura Thickness and Pachymeningeal Enhancement (1386)

Neurology, 2021-04, Vol.96 (15_supplement)

2021

Volltextzugriff (PDF)

Adherence to Prophylactic Anticonvulsant Guidelines for Newly Diagnosed Brain Tumor Patients: A Quality Improvement Study

Journal of the advanced practitioner in oncology, 2022-11, Vol.13 (8), p.775-789

2022

Volltextzugriff (PDF)

1 – 25 von 179

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(161)
Mit Volltextzugriff
(153)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(11)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201

Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment

Successful Consolidation/Maintenance Therapy with Single Agent Ibrutinib for Primary CNS Lymphoma after Initial Induction Therapy

Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4 + T-lymphocyte counts

A High-Grade Glioma, Not Elsewhere Classified in an Older Adult with Discordant Genetic and Epigenetic Analyses

Therapeutic Immunization against Glioblastoma

Intracranial meningioma with carcinoma tumor-to-tumor metastasis: two case reports

A Retrospective Interventional Cohort Study to Assess the Safety and Efficacy of Sandostatin LAR for Treatment of Recurrent and/or Refractory Meningiomas

Cytarabine Induced Acute Cerebellar Syndrome during Hyper-CVAD Treatment for B-Cell Acute Lymphoblastic Leukemia

A non-enhancing, T2 fluid-attenuated inversion recovery hyperintense, diffusion-restricting brainstem lesion in an EGFR tyrosine kinase inhibitor-treated non-small-cell lung cancer patient

331 Tumor markers associated with increased survival in a phase II trial of dendritic cell/tumor-initiating-cell vaccine AV-GBM-1 in patients with newly diagnosed glioblastoma

333 Changes in proteomic markers after injections of personal AV-GBM-1 dendritic cell/tumor initiating cell vaccines in a phase II trial in patients with newly diagnosed glioblastoma

319 Phase II trial of immunotherapy in primary glioblastoma: antigens from self-renewing autologous tumor cells presented by autologous dendritic cell vaccine

Dabrafenib and steroids for the treatment of Erdheim-Chester disease with extensive CNS involvement: a case report

Big Potassium (BK) ion channels in biology, disease and possible targets for cancer immunotherapy

Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment

Successful desensitization protocol for delayed cutaneous eruption to temozolomide

p53 Mutants Have Selective Dominant-Negative Effects on Apoptosis but Not Growth Arrest in Human Cancer Cell Lines

Mechanisms of Differential Activation of Target Gene Promoters by p53 Hinge Domain Mutants with Impaired Apoptotic Function

NIMG-78. THE ROLE OF FDG PET/CT IN MANAGING DIFFUSE MIDLINE GLIOMA WITH H3K27M MUTATION: A CASE STUDY AND PATHOLOGICAL CORRELATION

NCOG-17. RETROSPECTIVE REVIEW OF THE TREATMENT OF VENOUS THROMBOEMBOLISM IN GLIOBLASTOMA PATIENTS RECEIVING BEVACIZUMAB

IMMU-54. PNEUMOCYSTIS JIROVECII PNEUMONIA INFECTION IN A PATIENT WITH ANAPLASTIC ASTROCYTOMA AND RADIATION NECROSIS IN THE SETTING OF CORTICOSTEROID AND PEMBROLIZUMAB USE

Rare Case of Primary Dural Based Marginal Zone B-Cell Lymphoma Camouflaging as Mild Focal Dura Thickness and Pachymeningeal Enhancement (1386)

Adherence to Prophylactic Anticonvulsant Guidelines for Newly Diagnosed Brain Tumor Patients: A Quality Improvement Study

Suchergebnisse filtern